Thermal power plants amounts to nearly 70% of all generated electricity worldwide, but also accounts for about one third of the global carbon dioxide emissions. By finding improved high temperature materials, thermal power plants can run more effectively to a lower cost, both economically and environmentally.
Imperial Innovations' portfolio company, Oxford Immunotec Global PLC (NASDAQ: OXFD), has received a Queen’s Award for Enterprise – the UK’s highest accolade in business success.
King's has been awarded funding as part of a £500 million investment in Centres for Doctoral Training (CDTs), by EPSRC, to support a new centre in the area of non-equilibrium systems: CANES.
A team of researchers from five Swedish universities, led by Karolinska Institutet and the Science for Life Laboratory, have identified a new way of treating cancer. The concept is presented in the journal Nature and is based on inhibiting a specific enzyme called MTH1, which cancer cells, unlike normal cells, require for survival. Without this enzyme, oxidized nucleotides are incorporated into DNA, resulting in lethal DNA double-strand breaks in cancer cells.
With the new 3D Bioprinter, the research group of Professor Paul Gatenholm at the Department of Chemical and Biological Engineering exploits new possibilities of tissue engineering and organ regeneration.
Fifty-five of the world's most academically brilliant and socially committed young people from 27 countries have been selected as Gates Cambridge Scholars and will begin their postgraduate courses at the University of Cambridge this October.
The Mayor of London Boris Johnson launched MedCity, a major new medical research and translation initiative, at Imperial College London today [Tuesday 8 April].
The two universities signed an agreement to create a joint research laboratory devoted to automation and robotics. The two universities also announced a new joint master’s degree in civil engineering.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.